Abstract
Background: Many melanoma observational studies have been carried out across different countries and geographic areas using heterogeneous assessments of epidemiologic risk factors and clinical variables. Aim: To develop a consensus questionnaire to standardize epidemiologic and clinical data collection for melanoma risk assessment. Methods: We used a stepwise strategy that included: compilation of variables from case–control datasets collected at various centres of the MelaNostrum Consortium; integration of variables from published case–control studies; consensus discussion of the collected items by MelaNostrum members; revision by independent experts; addition of online tools and image-based charts; questionnaire testing across centres and generation of a final draft. Results: We developed a core consensus questionnaire (MelanoQ) that includes four separate sections: A. general and demographic data; B. phenotypic and ultraviolet radiation exposure risk factors and lifestyle habits; C. clinical examination, medical and family history; and D. diagnostic data on melanoma (cases only). Accompanying online tools, informative tables, and image-based charts aid standardization. Different subsections of the questionnaire are designed for self-administration, patient interviews performed by a physician or study nurse, and data collection from medical records. Conclusions: The MelanoQ questionnaire is a useful tool for the collection and standardization of epidemiologic and clinical data across different studies, centres, cultures and languages. This will expedite ongoing efforts to compile high-quality data for pooled analyses or meta-analyses and offer a solid base for the design of clinical, epidemiologic and translational studies on melanoma.
| Original language | English |
|---|---|
| Pages (from-to) | 2134-2141 |
| Number of pages | 8 |
| Journal | Journal of the European Academy of Dermatology and Venereology |
| Volume | 32 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - 2018 |
Fingerprint
ASJC Scopus subject areas
- Dermatology
- Infectious Diseases
Cite this
MelaNostrum : a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortium. / Stratigos, Alexander J.; Fargnoli, Maria Concetta; De Nicolo, Arcangela; Peris, Ketty; Puig, Susana; Soura, Efthymia; Menin, Chiara; Calista, Donato; Ghiorzo, Paola; Mandala, Mario; Massi, Daniela; Rodolfo, Monica; Del Regno, Laura; Stefanaki, Irene; Gogas, Helen; Bataille, Veronique; Tucker, Margaret A.; Whiteman, David; Nagore, Eduardo; Landi, Maria Teresa.
In: Journal of the European Academy of Dermatology and Venereology, Vol. 32, No. 12, 2018, p. 2134-2141.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - MelaNostrum
T2 - a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortium
AU - Stratigos, Alexander J.
AU - Fargnoli, Maria Concetta
AU - De Nicolo, Arcangela
AU - Peris, Ketty
AU - Puig, Susana
AU - Soura, Efthymia
AU - Menin, Chiara
AU - Calista, Donato
AU - Ghiorzo, Paola
AU - Mandala, Mario
AU - Massi, Daniela
AU - Rodolfo, Monica
AU - Del Regno, Laura
AU - Stefanaki, Irene
AU - Gogas, Helen
AU - Bataille, Veronique
AU - Tucker, Margaret A.
AU - Whiteman, David
AU - Nagore, Eduardo
AU - Landi, Maria Teresa
PY - 2018
Y1 - 2018
N2 - Background: Many melanoma observational studies have been carried out across different countries and geographic areas using heterogeneous assessments of epidemiologic risk factors and clinical variables. Aim: To develop a consensus questionnaire to standardize epidemiologic and clinical data collection for melanoma risk assessment. Methods: We used a stepwise strategy that included: compilation of variables from case–control datasets collected at various centres of the MelaNostrum Consortium; integration of variables from published case–control studies; consensus discussion of the collected items by MelaNostrum members; revision by independent experts; addition of online tools and image-based charts; questionnaire testing across centres and generation of a final draft. Results: We developed a core consensus questionnaire (MelanoQ) that includes four separate sections: A. general and demographic data; B. phenotypic and ultraviolet radiation exposure risk factors and lifestyle habits; C. clinical examination, medical and family history; and D. diagnostic data on melanoma (cases only). Accompanying online tools, informative tables, and image-based charts aid standardization. Different subsections of the questionnaire are designed for self-administration, patient interviews performed by a physician or study nurse, and data collection from medical records. Conclusions: The MelanoQ questionnaire is a useful tool for the collection and standardization of epidemiologic and clinical data across different studies, centres, cultures and languages. This will expedite ongoing efforts to compile high-quality data for pooled analyses or meta-analyses and offer a solid base for the design of clinical, epidemiologic and translational studies on melanoma.
AB - Background: Many melanoma observational studies have been carried out across different countries and geographic areas using heterogeneous assessments of epidemiologic risk factors and clinical variables. Aim: To develop a consensus questionnaire to standardize epidemiologic and clinical data collection for melanoma risk assessment. Methods: We used a stepwise strategy that included: compilation of variables from case–control datasets collected at various centres of the MelaNostrum Consortium; integration of variables from published case–control studies; consensus discussion of the collected items by MelaNostrum members; revision by independent experts; addition of online tools and image-based charts; questionnaire testing across centres and generation of a final draft. Results: We developed a core consensus questionnaire (MelanoQ) that includes four separate sections: A. general and demographic data; B. phenotypic and ultraviolet radiation exposure risk factors and lifestyle habits; C. clinical examination, medical and family history; and D. diagnostic data on melanoma (cases only). Accompanying online tools, informative tables, and image-based charts aid standardization. Different subsections of the questionnaire are designed for self-administration, patient interviews performed by a physician or study nurse, and data collection from medical records. Conclusions: The MelanoQ questionnaire is a useful tool for the collection and standardization of epidemiologic and clinical data across different studies, centres, cultures and languages. This will expedite ongoing efforts to compile high-quality data for pooled analyses or meta-analyses and offer a solid base for the design of clinical, epidemiologic and translational studies on melanoma.
UR - http://www.scopus.com/inward/record.url?scp=85053438956&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85053438956&partnerID=8YFLogxK
U2 - 10.1111/jdv.15208
DO - 10.1111/jdv.15208
M3 - Article
AN - SCOPUS:85053438956
VL - 32
SP - 2134
EP - 2141
JO - Journal of the European Academy of Dermatology and Venereology
JF - Journal of the European Academy of Dermatology and Venereology
SN - 0926-9959
IS - 12
ER -